Daxor Corporation Cash Flow Conversion Efficiency
Daxor Corporation cash flow conversion efficiency. Based on the latest financial reports, Daxor Corporation (DXR) has a cash flow conversion efficiency ratio of 0.013x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($467.04K) by net assets ($35.63 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Daxor Corporation (1985–2024)
Cash flow conversion efficiency of Daxor Corporation from 1985 to 2024. This chart illustrates how Daxor Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Daxor Corporation (DXR) share price today for real-time trading data and today's change.
Daxor Corporation Cash Flow Conversion Ratio Explained
Daxor Corporation cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Daxor Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Daxor Corporation ranked by their cash flow conversion efficiency. Also see market cap of Daxor Corporation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sangsangin Ian No.1 Special Purpose Acquisition Co. Ltd
KQ:307870
|
-0.030x |
|
Bonus Biogroup
TA:BONS
|
0.710x |
|
Shuang-Bang Industrial
TWO:6506
|
0.035x |
|
eMedia Holdings Limited
JSE:EMN
|
0.031x |
|
DURECT CORP. DL-001
F:DC8A
|
N/A |
|
Krungdhep Sophon Public Company Limited
BK:KWC
|
0.046x |
|
Logan Ridge Finance Corp
NASDAQ:LRFC
|
-0.015x |
|
Yatra Online Inc
NASDAQ:YTRA
|
-0.051x |
Annual Cash Flow Conversion Efficiency for Daxor Corporation (1985–2024)
The table below shows the annual cash flow conversion efficiency of Daxor Corporation from 1985 to 2024. Review Daxor Corporation free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $35.79 Million | $25.69K | 0.001x | +100.67% |
| 2023-12-31 | $34.01 Million | $-3.66 Million | -0.107x | -304.70% |
| 2022-12-31 | $28.97 Million | $-769.30K | -0.027x | +79.64% |
| 2021-12-31 | $21.15 Million | $-2.76 Million | -0.130x | +16.47% |
| 2020-12-31 | $15.68 Million | $-2.45 Million | -0.156x | -164.05% |
| 2019-12-31 | $12.77 Million | $3.11 Million | 0.244x | +342.04% |
| 2018-12-31 | $13.06 Million | $-1.32 Million | -0.101x | -18.18% |
| 2017-12-31 | $13.76 Million | $-1.17 Million | -0.085x | -182.11% |
| 2016-12-31 | $15.34 Million | $1.59 Million | 0.104x | -91.92% |
| 2015-12-31 | $14.43 Million | $18.53 Million | 1.284x | +10776.23% |
| 2014-12-31 | $24.58 Million | $-295.64K | -0.012x | +96.49% |
| 2013-12-31 | $26.37 Million | $-9.04 Million | -0.343x | -368.80% |
| 2012-12-31 | $35.11 Million | $4.48 Million | 0.128x | +170.98% |
| 2011-12-31 | $36.22 Million | $-6.51 Million | -0.180x | -48.43% |
| 2010-12-31 | $47.00 Million | $-5.69 Million | -0.121x | -9.77% |
| 2009-12-31 | $47.63 Million | $-5.25 Million | -0.110x | -18.67% |
| 2008-12-31 | $43.46 Million | $-4.04 Million | -0.093x | -62.40% |
| 2007-12-31 | $54.92 Million | $-3.14 Million | -0.057x | +24.08% |
| 2006-12-31 | $45.64 Million | $-3.44 Million | -0.075x | -152.57% |
| 2005-12-31 | $38.74 Million | $-1.16 Million | -0.030x | +34.97% |
| 2004-12-31 | $39.88 Million | $-1.83 Million | -0.046x | -51.31% |
| 2003-12-31 | $36.42 Million | $-1.10 Million | -0.030x | -378.23% |
| 2002-12-31 | $33.55 Million | $-212.77K | -0.006x | -201.10% |
| 2001-12-31 | $35.33 Million | $221.63K | 0.006x | +327.81% |
| 2000-12-31 | $38.67 Million | $-106.49K | -0.003x | +82.89% |
| 1999-12-31 | $29.28 Million | $-471.20K | -0.016x | +28.99% |
| 1998-12-31 | $35.30 Million | $-800.00K | -0.023x | -286.40% |
| 1997-12-31 | $32.90 Million | $400.00K | 0.012x | +93.31% |
| 1996-12-31 | $31.80 Million | $200.00K | 0.006x | -32.70% |
| 1995-12-31 | $32.10 Million | $300.00K | 0.009x | -70.93% |
| 1994-12-31 | $31.10 Million | $1.00 Million | 0.032x | -39.65% |
| 1993-12-31 | $24.40 Million | $1.30 Million | 0.053x | -48.34% |
| 1992-12-31 | $22.30 Million | $2.30 Million | 0.103x | +64.16% |
| 1991-12-31 | $19.10 Million | $1.20 Million | 0.063x | -42.64% |
| 1990-12-31 | $21.00 Million | $2.30 Million | 0.110x | +509.62% |
| 1989-12-31 | $18.70 Million | $-500.00K | -0.027x | -114.94% |
| 1988-12-31 | $19.00 Million | $3.40 Million | 0.179x | +59.93% |
| 1986-12-31 | $14.30 Million | $1.60 Million | 0.112x | -19.81% |
| 1985-12-31 | $12.90 Million | $1.80 Million | 0.140x | -- |
About Daxor Corporation
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corpo… Read more